行情

CSBR

CSBR

Champions
NASDAQ

实时行情|Nasdaq Last Sale

6.00
-0.08
-1.32%
盘后: 6.00 0 0.00% 16:00 09/20 EDT
开盘
6.24
昨收
6.08
最高
6.24
最低
5.98
成交量
11.45万
成交额
--
52周最高
17.90
52周最低
5.20
市值
6,971.72万
市盈率(TTM)
-66.6667
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CSBR 新闻

  • "央行的央行"报告:金融危机都无法想象的情景出现了
  • 新浪财经综合.1小时前
  • 日媒:世界金融深陷负利率引担忧
  • 参考消息.2小时前
  • 老债王格罗斯父子反目 因价值数百万美元孤品邮票
  • 新浪财经.2小时前
  • 替代美元 俄罗斯已找到方案
  • 参考消息.2小时前

更多

所属板块

生物技术和医学研究
+0.62%
制药与医学研究
+0.95%

热门股票

名称
价格
涨跌幅

CSBR 简况

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
展开

Webull提供Champions Oncology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。